FZD6 is also consistently expressed in the LuCaP PDX models representing a wide spectrum of prostate cancer genotypes and phenotypes including CRPC, DNPC, and NEPC (Fig. 1B). This evidence concerns the gene FZD6 and prostate carcinoma.